Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alena V. Savinkova
Observed names:
A. Savinkova,
A. V. Savinkova,
A.V. Savinkova Savinkova,
Alena V Savinkova,
А В Савинкова,
Савинкова Алена Валерьевна
show all 6
Institutions:
Moscow Clinical Scientific Center,
Russian Cancer Research Center NN Blokhin
Observed institutions:
D. Mendeleyev University of Chemical Technology of Russia,
Moscow Clinical Scientific Center,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0000-0001-9664-0931
Observed ORCID:
0000-0001-9664-0931
OpenAlex ID:
A5012398946
A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
2020
·
Ekaterina M Zhidkova
, Evgeniya S Lylova
, et al.
·
Breast Cancer Basic and Clinical Research
·
30
PDF
A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition
2020
·
Ekaterina A. Lesovaya
, Alena V. Savinkova
, et al.
·
Molecular Cancer Therapeutics
·
11
Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-naïve prostate cancer
2019
·
V.B. Matveev Matveev
, A.A. Kirichek Kirichek
, et al.
·
Urologiia
·
11
Variants and Perspectives of Drug Repurposing for Cancer Treatment
2018
·
A. V. Savinkova
, E. M. Zhidkova
, et al.
·
Siberian Journal of Oncology
·
10
PDF
Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer
2018
·
V. B. Matveev
, A. A. Kirichek
, et al.
·
Cancer Urology
·
6
PDF
Comparative Analysis of Biological Effects of Selective Activator of the Glucocorticoid Receptor Cpda on Different Subtypes of Breast Cancer Cell Lines
2017
·
E. M. Zhidkova
, K. A. Kuzin
, et al.
·
Siberian Journal of Oncology
·
6
PDF
Anti-tumor Effect of Cpda Enantiomers in Vitro in the Model of Acute Lymphoblastic Leukemia
2017
·
A. V. Savinkova
, L. R. Tilova
, et al.
·
Russian Journal of Biotherapy
·
3
PDF
Inhibition of Redd1 Expression for the Reduction of Glucocorticoid-induced Side Effects
2020
·
E. S. Lylova
, A. V. Savinkova
, et al.
·
Siberian Journal of Oncology
·
2
PDF
Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems
2017
·
L. R. Tilova
, A. V. Savinkova
, et al.
·
Clinical oncohematology
·
1
PDF
Data from A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition
2023
·
Ekaterina A. Lesovaya
, Alena V. Savinkova
, et al.
Supplementary Figures 1-9 from A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition
2023
·
Ekaterina A. Lesovaya
, Alena V. Savinkova
, et al.
PDF
Supplementary Figures 1-9 from A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition
2023
·
Ekaterina A. Lesovaya
, Alena V. Savinkova
, et al.
Supplementary Tables 1-3 from A Novel Approach to Safer Glucocorticoid Receptor–Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition
2023
·
Ekaterina A. Lesovaya
, Alena V. Savinkova
, et al.
Differential regulation of glucocorticoid receptor signaling in luminal, triple negative and HER2+ breast cancer cells
2019
·
E. Zhidkova
, V. Maksimova
, et al.
·
Annals of Oncology
PO-260 Anti-lymphoma activity of novel selective glucocorticoid receptor agonists (SEGRAs) in vitro and in vivo
2018
·
E. Lesovaya
, L. Tilova
, et al.
·
ESMO Open
CpdA как коадъювант в терапии рака молочной железы
2017
·
Ekaterina M. Zhidkova
, М А Мазин
, et al.
·
Российский биотерапевтический журнал
P85
2015
·
L. Tilova
, O. Zadorozhnaya
, et al.
·
European Journal of Cancer Supplements
PDF
T25
2015
·
E. Lesovaya
, L. Tilova
, et al.
·
European Journal of Cancer Supplements
PDF
Show more works
View as search
Works count:
19
Citation count:
80
H-index:
6
I10-index:
4
Year
Topic
Type